HEADER TRANSFERASE 03-MAY-18 6GGH TITLE HUMAN JAK1 KINASE DOMAIN IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: JANUS KINASE 1,JAK-1; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS JANUS KINASE 1 KINASE DOMAIN (JAK1), TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.READ,M.AUGUSTIN,A.LAMMENS REVDAT 2 17-JAN-24 6GGH 1 REMARK REVDAT 1 22-MAY-19 6GGH 0 JRNL AUTH M.NILSSON JRNL TITL INHIBITION OF LOCAL LUNG INFLAMMATION BY A POTENT AND JRNL TITL 2 SELECTIVE JAK1 INHIBITOR; ACTIVATION OF JAK1, BUT NOT JAK3, JRNL TITL 3 IS CRITICAL TO IL-4R MEDIATED IMMUNE CELL SIGNALLING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 85.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 64937 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 3160 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4550 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 239 REMARK 3 BIN FREE R VALUE : 0.3970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 346 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.80000 REMARK 3 B22 (A**2) : 2.30000 REMARK 3 B33 (A**2) : -0.59000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.64000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.167 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.128 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.109 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.507 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4798 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3362 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6497 ; 1.297 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8158 ; 1.815 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 579 ; 5.693 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 209 ;38.618 ;24.306 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 847 ;12.451 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;16.290 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 696 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5272 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 955 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8160 ; 8.053 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 129 ;29.031 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 8272 ;15.754 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6GGH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200009875. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68097 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 85.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3EYG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% (M/V) PEG6000, 0.1 M MES/NAOH PH REMARK 280 6.0 AND 5 MM DTT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 85.16350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 863 REMARK 465 GLU A 864 REMARK 465 GLU A 946 REMARK 465 ASP A 947 REMARK 465 GLY A 948 REMARK 465 GLY A 949 REMARK 465 LYS B 911 REMARK 465 PRO B 912 REMARK 465 GLU B 913 REMARK 465 SER B 914 REMARK 465 GLY B 915 REMARK 465 GLU B 946 REMARK 465 ASP B 947 REMARK 465 GLY B 948 REMARK 465 GLY B 949 REMARK 465 ASN B 950 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 872 CE NZ REMARK 480 HIS A 885 CG ND1 CD2 CE1 NE2 REMARK 480 PHE A 886 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS A 888 NZ REMARK 480 ASN A 917 CG OD1 ND2 REMARK 480 LYS A 970 CE NZ REMARK 480 ASP A 1031 CG OD1 OD2 REMARK 480 LYS A 1032 CE NZ REMARK 480 ASP A 1042 CG OD1 OD2 REMARK 480 THR A 1095 OG1 CG2 REMARK 480 GLU A 1110 CD OE1 OE2 REMARK 480 LYS A 1154 CD CE NZ REMARK 480 HIS B 885 CG ND1 CD2 CE1 NE2 REMARK 480 PHE B 886 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS B 888 CD CE NZ REMARK 480 ASN B 917 CG OD1 ND2 REMARK 480 LYS B 924 CE NZ REMARK 480 GLU B 935 CD OE1 OE2 REMARK 480 LYS B 970 CE NZ REMARK 480 LYS B 1038 CE NZ REMARK 480 ASP B 1039 CG OD1 OD2 REMARK 480 ASP B 1042 CG OD1 OD2 REMARK 480 LYS B 1090 CD CE NZ REMARK 480 PRO B 1094 CG CD REMARK 480 THR B 1095 OG1 CG2 REMARK 480 LYS B 1130 CE NZ REMARK 480 LYS B 1154 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A1096 CG HIS A1096 CD2 0.065 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 878 -60.46 -94.32 REMARK 500 PHE A 886 -10.02 77.28 REMARK 500 ASP A1003 35.73 -149.83 REMARK 500 ASP A1040 44.71 -103.19 REMARK 500 HIS A1096 -20.09 107.17 REMARK 500 ASP B1003 35.70 -151.95 REMARK 500 ASP B1042 30.70 72.16 REMARK 500 THR B1095 -151.17 -82.59 REMARK 500 HIS B1096 -2.07 95.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1467 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH B1479 DISTANCE = 10.29 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EYQ A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EYQ B 1201 DBREF 6GGH A 863 1154 UNP P23458 JAK1_HUMAN 863 1154 DBREF 6GGH B 863 1154 UNP P23458 JAK1_HUMAN 863 1154 SEQRES 1 A 292 THR GLU VAL ASP PRO THR HIS PHE GLU LYS ARG PHE LEU SEQRES 2 A 292 LYS ARG ILE ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS SEQRES 3 A 292 VAL GLU LEU CYS ARG TYR ASP PRO GLU GLY ASP ASN THR SEQRES 4 A 292 GLY GLU GLN VAL ALA VAL LYS SER LEU LYS PRO GLU SER SEQRES 5 A 292 GLY GLY ASN HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU SEQRES 6 A 292 ILE LEU ARG ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR SEQRES 7 A 292 LYS GLY ILE CYS THR GLU ASP GLY GLY ASN GLY ILE LYS SEQRES 8 A 292 LEU ILE MET GLU PHE LEU PRO SER GLY SER LEU LYS GLU SEQRES 9 A 292 TYR LEU PRO LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN SEQRES 10 A 292 GLN LEU LYS TYR ALA VAL GLN ILE CYS LYS GLY MET ASP SEQRES 11 A 292 TYR LEU GLY SER ARG GLN TYR VAL HIS ARG ASP LEU ALA SEQRES 12 A 292 ALA ARG ASN VAL LEU VAL GLU SER GLU HIS GLN VAL LYS SEQRES 13 A 292 ILE GLY ASP PHE GLY LEU THR LYS ALA ILE GLU THR ASP SEQRES 14 A 292 LYS GLU PTR PTR THR VAL LYS ASP ASP ARG ASP SER PRO SEQRES 15 A 292 VAL PHE TRP TYR ALA PRO GLU CYS LEU MET GLN SER LYS SEQRES 16 A 292 PHE TYR ILE ALA SER ASP VAL TRP SER PHE GLY VAL THR SEQRES 17 A 292 LEU HIS GLU LEU LEU THR TYR CYS ASP SER ASP SER SER SEQRES 18 A 292 PRO MET ALA LEU PHE LEU LYS MET ILE GLY PRO THR HIS SEQRES 19 A 292 GLY GLN MET THR VAL THR ARG LEU VAL ASN THR LEU LYS SEQRES 20 A 292 GLU GLY LYS ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP SEQRES 21 A 292 GLU VAL TYR GLN LEU MET ARG LYS CYS TRP GLU PHE GLN SEQRES 22 A 292 PRO SER ASN ARG THR SER PHE GLN ASN LEU ILE GLU GLY SEQRES 23 A 292 PHE GLU ALA LEU LEU LYS SEQRES 1 B 292 THR GLU VAL ASP PRO THR HIS PHE GLU LYS ARG PHE LEU SEQRES 2 B 292 LYS ARG ILE ARG ASP LEU GLY GLU GLY HIS PHE GLY LYS SEQRES 3 B 292 VAL GLU LEU CYS ARG TYR ASP PRO GLU GLY ASP ASN THR SEQRES 4 B 292 GLY GLU GLN VAL ALA VAL LYS SER LEU LYS PRO GLU SER SEQRES 5 B 292 GLY GLY ASN HIS ILE ALA ASP LEU LYS LYS GLU ILE GLU SEQRES 6 B 292 ILE LEU ARG ASN LEU TYR HIS GLU ASN ILE VAL LYS TYR SEQRES 7 B 292 LYS GLY ILE CYS THR GLU ASP GLY GLY ASN GLY ILE LYS SEQRES 8 B 292 LEU ILE MET GLU PHE LEU PRO SER GLY SER LEU LYS GLU SEQRES 9 B 292 TYR LEU PRO LYS ASN LYS ASN LYS ILE ASN LEU LYS GLN SEQRES 10 B 292 GLN LEU LYS TYR ALA VAL GLN ILE CYS LYS GLY MET ASP SEQRES 11 B 292 TYR LEU GLY SER ARG GLN TYR VAL HIS ARG ASP LEU ALA SEQRES 12 B 292 ALA ARG ASN VAL LEU VAL GLU SER GLU HIS GLN VAL LYS SEQRES 13 B 292 ILE GLY ASP PHE GLY LEU THR LYS ALA ILE GLU THR ASP SEQRES 14 B 292 LYS GLU PTR PTR THR VAL LYS ASP ASP ARG ASP SER PRO SEQRES 15 B 292 VAL PHE TRP TYR ALA PRO GLU CYS LEU MET GLN SER LYS SEQRES 16 B 292 PHE TYR ILE ALA SER ASP VAL TRP SER PHE GLY VAL THR SEQRES 17 B 292 LEU HIS GLU LEU LEU THR TYR CYS ASP SER ASP SER SER SEQRES 18 B 292 PRO MET ALA LEU PHE LEU LYS MET ILE GLY PRO THR HIS SEQRES 19 B 292 GLY GLN MET THR VAL THR ARG LEU VAL ASN THR LEU LYS SEQRES 20 B 292 GLU GLY LYS ARG LEU PRO CYS PRO PRO ASN CYS PRO ASP SEQRES 21 B 292 GLU VAL TYR GLN LEU MET ARG LYS CYS TRP GLU PHE GLN SEQRES 22 B 292 PRO SER ASN ARG THR SER PHE GLN ASN LEU ILE GLU GLY SEQRES 23 B 292 PHE GLU ALA LEU LEU LYS MODRES 6GGH PTR A 1034 TYR MODIFIED RESIDUE MODRES 6GGH PTR A 1035 TYR MODIFIED RESIDUE MODRES 6GGH PTR B 1034 TYR MODIFIED RESIDUE MODRES 6GGH PTR B 1035 TYR MODIFIED RESIDUE HET PTR A1034 16 HET PTR A1035 16 HET PTR B1034 16 HET PTR B1035 16 HET EYQ A1201 34 HET EYQ B1201 34 HETNAM PTR O-PHOSPHOTYROSINE HETNAM EYQ ~{N}-[5-METHYL-4-[7-[[(2~{R})-2-(4-METHYLPIPERAZIN-1- HETNAM 2 EYQ YL)PROPANOYL]AMINO]-1~{H}-INDOL-3-YL]PYRIMIDIN-2- HETNAM 3 EYQ YL]CYCLOPROPANECARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 EYQ 2(C25 H31 N7 O2) FORMUL 5 HOH *346(H2 O) HELIX 1 AA1 GLU A 871 ARG A 873 5 3 HELIX 2 AA2 GLY A 916 ASN A 931 1 16 HELIX 3 AA3 SER A 963 LEU A 968 1 6 HELIX 4 AA4 ASN A 976 ARG A 997 1 22 HELIX 5 AA5 ALA A 1005 ARG A 1007 5 3 HELIX 6 AA6 PRO A 1044 TYR A 1048 5 5 HELIX 7 AA7 ALA A 1049 SER A 1056 1 8 HELIX 8 AA8 TYR A 1059 THR A 1076 1 18 HELIX 9 AA9 ASP A 1079 SER A 1082 5 4 HELIX 10 AB1 SER A 1083 GLY A 1093 1 11 HELIX 11 AB2 HIS A 1096 GLN A 1098 5 3 HELIX 12 AB3 MET A 1099 GLY A 1111 1 13 HELIX 13 AB4 PRO A 1121 TRP A 1132 1 12 HELIX 14 AB5 GLN A 1135 ARG A 1139 5 5 HELIX 15 AB6 SER A 1141 LYS A 1154 1 14 HELIX 16 AB7 GLU B 871 ARG B 873 5 3 HELIX 17 AB8 ASN B 917 ASN B 931 1 15 HELIX 18 AB9 SER B 963 LYS B 972 1 10 HELIX 19 AC1 ASN B 976 ARG B 997 1 22 HELIX 20 AC2 ALA B 1005 ARG B 1007 5 3 HELIX 21 AC3 PRO B 1044 TYR B 1048 5 5 HELIX 22 AC4 ALA B 1049 SER B 1056 1 8 HELIX 23 AC5 ILE B 1060 THR B 1076 1 17 HELIX 24 AC6 ASP B 1079 SER B 1082 5 4 HELIX 25 AC7 SER B 1083 GLY B 1093 1 11 HELIX 26 AC8 HIS B 1096 GLN B 1098 5 3 HELIX 27 AC9 MET B 1099 GLU B 1110 1 12 HELIX 28 AD1 PRO B 1121 CYS B 1131 1 11 HELIX 29 AD2 GLN B 1135 ARG B 1139 5 5 HELIX 30 AD3 SER B 1141 LYS B 1154 1 14 SHEET 1 AA1 5 LEU A 875 GLU A 883 0 SHEET 2 AA1 5 GLY A 887 TYR A 894 -1 O LEU A 891 N ILE A 878 SHEET 3 AA1 5 GLU A 903 LEU A 910 -1 O VAL A 907 N GLU A 890 SHEET 4 AA1 5 LYS A 953 GLU A 957 -1 O LEU A 954 N LYS A 908 SHEET 5 AA1 5 TYR A 940 CYS A 944 -1 N GLY A 942 O ILE A 955 SHEET 1 AA2 2 TYR A 999 VAL A1000 0 SHEET 2 AA2 2 LYS A1026 ALA A1027 -1 O LYS A1026 N VAL A1000 SHEET 1 AA3 2 VAL A1009 SER A1013 0 SHEET 2 AA3 2 GLN A1016 ILE A1019 -1 O LYS A1018 N LEU A1010 SHEET 1 AA4 2 PTR A1035 THR A1036 0 SHEET 2 AA4 2 LYS A1057 PHE A1058 -1 O PHE A1058 N PTR A1035 SHEET 1 AA5 5 LEU B 875 GLU B 883 0 SHEET 2 AA5 5 LYS B 888 TYR B 894 -1 O LEU B 891 N ARG B 879 SHEET 3 AA5 5 GLU B 903 SER B 909 -1 O VAL B 905 N CYS B 892 SHEET 4 AA5 5 LYS B 953 GLU B 957 -1 O LEU B 954 N LYS B 908 SHEET 5 AA5 5 TYR B 940 CYS B 944 -1 N GLY B 942 O ILE B 955 SHEET 1 AA6 2 TYR B 999 VAL B1000 0 SHEET 2 AA6 2 LYS B1026 ALA B1027 -1 O LYS B1026 N VAL B1000 SHEET 1 AA7 2 VAL B1009 SER B1013 0 SHEET 2 AA7 2 GLN B1016 ILE B1019 -1 O LYS B1018 N LEU B1010 SHEET 1 AA8 2 PTR B1034 THR B1036 0 SHEET 2 AA8 2 LYS B1057 TYR B1059 -1 O PHE B1058 N PTR B1035 LINK C GLU A1033 N PTR A1034 1555 1555 1.33 LINK C PTR A1034 N PTR A1035 1555 1555 1.33 LINK C PTR A1035 N THR A1036 1555 1555 1.34 LINK C GLU B1033 N PTR B1034 1555 1555 1.33 LINK C PTR B1034 N PTR B1035 1555 1555 1.33 LINK C PTR B1035 N THR B1036 1555 1555 1.34 SITE 1 AC1 20 LEU A 881 GLY A 882 VAL A 889 ALA A 906 SITE 2 AC1 20 GLU A 957 PHE A 958 LEU A 959 PRO A 960 SITE 3 AC1 20 GLY A 962 GLU A 966 ASP A1003 ARG A1007 SITE 4 AC1 20 ASN A1008 LEU A1010 GLY A1020 ASP A1021 SITE 5 AC1 20 HOH A1344 HOH A1358 HOH A1381 HOH A1412 SITE 1 AC2 19 LEU B 881 GLY B 882 ALA B 906 GLU B 957 SITE 2 AC2 19 PHE B 958 LEU B 959 PRO B 960 GLY B 962 SITE 3 AC2 19 GLU B 966 ASP B1003 ARG B1007 ASN B1008 SITE 4 AC2 19 LEU B1010 GLY B1020 ASP B1021 ASP B1042 SITE 5 AC2 19 HOH B1316 HOH B1362 HOH B1430 CRYST1 42.987 170.327 45.026 90.00 94.06 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023263 0.000000 0.001652 0.00000 SCALE2 0.000000 0.005871 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022265 0.00000